Gary B. Evans
Impact in
- Physiology top 0.5%
- Adenosine and Purinergic Signaling
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
-
- Biochemical and Molecular Research 65
- Polyamine Metabolism and Applications 8
- Epidemiology 26
- Cytomegalovirus and herpesvirus research 13
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Trypanosoma species research and implications 6
- Co-authors
- Vern L. Schramm (66 shared papers)Peter C. Tyler (64 shared papers)Richard H. Furneaux (40 shared papers)Andrzej Lewandowicz (9 shared papers)Keith Clinch (18 shared papers)Steven C. Almo (17 shared papers)Vipender Singh (8 shared papers)Kami Kim (6 shared papers)
- Journals
- Biochemistry (18 papers)Journal of Biological Chemistry (11 papers)Journal of Medicinal Chemistry (10 papers)Bioorganic & Medicinal Chemistry (6 papers)Journal of the American Chemical Society (5 papers)
- Partner nations
- United StatesNew ZealandUnited Kingdom
In The Last Decade
Gary B. Evans
103 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 115
- Physiology 573
- Infectious Diseases 747
- Molecular Biology 2.5k
- Organic Chemistry 765
- Epidemiology 671
Countries citing papers authored by Gary B. Evans
This map shows the geographic impact of Gary B. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary B. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary B. Evans more than expected).
Fields of papers citing papers by Gary B. Evans
This network shows the impact of papers produced by Gary B. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary B. Evans. The network helps show where Gary B. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary B. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 163 | |
| 2 | 2005 | 115 | |
| 3 | 1999 | 113 | |
| 4 | 2003 | 98 | |
| 5 | 2004 | 94 | |
| 6 | 2004 | 91 | |
| 7 | 2002 | 89 | |
| 8 | 2003 | 81 | |
| 9 | 2001 | 79 | |
| 10 | 2002 | 78 | |
| 11 | 2008 | 74 | |
| 12 | 2010 | 68 | |
| 13 | 2000 | 67 | |
| 14 | 1999 | 66 | |
| 15 | 2009 | 65 | |
| 16 | 2003 | 65 | |
| 17 | 2005 | 64 | |
| 18 | 2003 | 64 | |
| 19 | 2006 | 60 | |
| 20 | 2003 | 60 |
About Gary B. Evans
Gary B. Evans is a scholar working on Molecular Biology, Epidemiology, Physiology, Infectious Diseases and Organic Chemistry, having authored 104 papers that have together received 3.4k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (65 papers), Adenosine and Purinergic Signaling (26 papers), HIV/AIDS drug development and treatment (22 papers), Cytomegalovirus and herpesvirus research (13 papers), Polyamine Metabolism and Applications (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Trypanosoma species research and implications (6 papers) and Toxin Mechanisms and Immunotoxins (5 papers). The work is most often cited by research in Physiology (573 citations), Infectious Diseases (747 citations), Molecular Biology (2.5k citations), Organic Chemistry (765 citations) and Epidemiology (671 citations). Gary B. Evans has collaborated with scholars based in United States, New Zealand and United Kingdom. Frequent co-authors include Vern L. Schramm, Peter C. Tyler, Richard H. Furneaux, Andrzej Lewandowicz, Keith Clinch, Steven C. Almo, Vipender Singh, Kami Kim, Wuxian Shi and Gregory Kicska. Their work appears in journals such as Biochemistry, Journal of Biological Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.